Connection

David Priest to Glutamates

This is a "connection" page, showing publications David Priest has written about Glutamates.
Connection Strength

0.074
  1. Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res. 2000 Jul; 6(7):2677-84.
    View in: PubMed
    Score: 0.043
  2. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res. 2001 May 01; 61(9):3675-81.
    View in: PubMed
    Score: 0.011
  3. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem. 1998 Nov 13; 273(46):30189-98.
    View in: PubMed
    Score: 0.010
  4. Inhibition of mammalian thymidylate synthase by 10-formyltetrahydropteroylpolyglutamate. Arch Biochem Biophys. 1991 Jan; 284(1):219-22.
    View in: PubMed
    Score: 0.006
  5. The effect of methionine on methotrexate metabolism in rat hepatocytes in monolayer culture. Biochim Biophys Acta. 1989 May 10; 1011(2-3):122-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.